6Hebert PR,Gaziano JM,Chan KS,et al.Cholesterol lowering with statin drugs,risk of stroke,and total mortality.An overview of randomized trials(J).J Am Med Assoc,2007;278(4):313-21.
4Rosenson RS. biological basis for statin therapy in stroke prevention[J]. Curr Opin Neurol, 2000,13: 57-62.
5Marti-Fabregas J, Gomis M , Arboix A , et al . Favorable outcome of ischemic stroke in patients pretreated with statins[J]. Stroke,2004,35(5):1117-1121.
6Zacco A, Togo J ,Spence K ,et al. 3-hydroxy-3-methy-lglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity[J]. J Neurosci,2003,23(35) :1104-1111.
7Chan Carusone S, Smieja M, Molloy W, et al. Lack of association between vascular dementia and Chlamydia pneumoniae infection: a case-control study. BMC Neurol 2004;4(1): 15
8Hashimoto H, Kitagawa K, Hougaku H, et al. Relationship between C-reactive protein and progression of early carotid atherosclerosis in hypertensive subjects. Stroke 2004; 35 (7) : 1625 - 30
9Patrick L, Uzick M. Cardiovascular disease: C-reactive protein and the inllammatory disease paradigm: HMG-CoA n~ductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature. Altern Med Rev 2001; 6(3):248 -71
10Yasojima K, Schwab C, McGeer EG, et al. Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol 2001; 158(3):1039 -51
